| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
CERo Therapeutics Holdings Inc is an immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (OTCQB:CERO) through any online brokerage.
There are no as such competitors for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc..
There is no analysis for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. to provide a consensus price target.
The stock price for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (OTCQB: CERO) is $0.0051 last updated October 22, 2026 at 3:40 PM EDT.
There are no upcoming dividends for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc..
CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc..
CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
